collection
MENU ▼
Read by QxMD icon Read
search

GDM

shared collection
3 papers 0 to 25 followers
By Chad Klauser Maternal Fetal Medicine physician in NYC
https://www.readbyqxmd.com/read/25315294/gestational-diabetes-mellitus-management-with-oral-hypoglycemic-agents
#1
REVIEW
Rachel J Ryu, Karen E Hays, Mary F Hebert
Oral hypoglycemic agents such as glyburide (second-generation sulfonylurea) and metformin (biguanide) are attractive alternatives to insulin due to lower cost, ease of administration, and better patient adherence. The majority of evidence from retrospective and prospective studies suggests comparable efficacy and safety of oral hypoglycemic agents such as glyburide and metformin as compared to insulin when used in the treatment of women with gestational diabetes mellitus (GDM). Glyburide and metformin have altered pharmacokinetics during pregnancy and both agents cross the placenta...
December 2014: Seminars in Perinatology
https://www.readbyqxmd.com/read/25261963/management-of-diabetes-and-pregnancy-when-to-start-and-what-pharmacological-agent-to-choose
#2
REVIEW
Liran Hiersch, Yariv Yogev
Gestational diabetes mellitus (GDM) complicates 3-15% of pregnancies depending upon the geographic location and ethnic groups, and its incidence is estimated to increase even further due to the increasing rates of obesity in the general population and the trend towards advanced maternal age in pregnancy. GDM is associated with adverse pregnancy outcome such as an increased rate of fetal macrosomia, neonatal metabolic disturbances, and maternal injuries. It has been shown that there is an inverse relation between maternal glycemic control and the risk of complications...
February 2015: Best Practice & Research. Clinical Obstetrics & Gynaecology
https://www.readbyqxmd.com/read/24861556/first-trimester-exposure-to-metformin-and-risk-of-birth-defects-a-systematic-review-and-meta-analysis
#3
REVIEW
Matteo Cassina, Marta DonĂ , Elena Di Gianantonio, Pietro Litta, Maurizio Clementi
BACKGROUND: Metformin is generally considered a non-teratogenic drug; however, only a few studies specifically designed to assess the rate of congenital anomalies after metformin use have been published in the literature. The objects of the present study were to review all of the prospective and retrospective studies reporting on women treated with metformin at least during the first trimester of their pregnancy and to estimate the overall rate of major birth defects. METHODS: Databases were searched for English language articles until December 2013...
September 2014: Human Reproduction Update
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"